Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Amdocs (DOX) Receives a Buy from Stifel Nicolaus

Tipranks - Tipranks - Wed Mar 25, 7:36AM CDT

Stifel Nicolaus analyst Shlomo Rosenbaum maintained a Buy rating on Amdocs today and set a price target of $88.00.

Claim 30% Off TipRanks Premium

According to TipRanks, Rosenbaum is a 4-star analyst with an average return of 3.3% and a 50.46% success rate. Rosenbaum covers the Financial sector, focusing on stocks such as S&P Global, Moody’s, and TransUnion.

Amdocs has an analyst consensus of Strong Buy, with a price target consensus of $92.33.

See today’s best-performing stocks on TipRanks >>

Based on Amdocs’ latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.16 billion and a net profit of $157.57 million. In comparison, last year the company earned a revenue of $1.11 billion and had a net profit of $151.13 million

Read More on DOX:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).